Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury
NESAKI
1 other identifier
observational
50
1 country
1
Brief Summary
Acute kidney injury (AKI) is a major organ failure in septic shock. Current medical tests (serum creatinine and urea) cannot identify AKI until approximately 48 hours after it occurs. Neutrophil gelatinase-associated lipocalin (NGAL) may be able to predict ischemic AKI more effectively and faster than serum creatinine and urea levels. The purpose of this study is to take a blood sample from patients at admission and then at 24 and 48 hours after to test their plasma for NGAL and compare the NGAL levels to their creatinine and urea levels. The investigators hypothesize that NGAL is an earlier marker to classify the kidney failure as acute tubular necrosis or pre-renal azotemia than creatinine and urea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 10, 2010
CompletedFirst Posted
Study publicly available on registry
May 13, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedMay 31, 2010
April 1, 2010
10 months
May 10, 2010
May 28, 2010
Conditions
Keywords
Study Arms (1)
Septic shock
Eligibility Criteria
patients of a medical intensive care presenting with a septic shock
You may qualify if:
- Patients showing signs of infection and hypotension requiring the use of epinephrine despite of an appropriate fluid challenge.
- years of age or older
You may not qualify if:
- Age under 18 years
- Prisoners or other institutionalized or vulnerable individuals
- Participation in an interventional clinical study within the previous 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Reanimation medicale, Hopital Saint-Andre, Bordeaux University Hospital
Bordeaux, Aquitaine, 33000, France
Biospecimen
Blood Sample (350 µl) at inclusion and then 24 and 48 hours after
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fabrice Camou, MD
University Hospital, Bordeaux
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 10, 2010
First Posted
May 13, 2010
Study Start
July 1, 2009
Primary Completion
May 1, 2010
Study Completion
June 1, 2010
Last Updated
May 31, 2010
Record last verified: 2010-04